Anagrelide Hydrochloride (Teva Pharmaceuticals USA, Inc)
Welcome to the PulseAid listing for the Anagrelide Hydrochloride drug offered from Teva Pharmaceuticals USA, Inc. This Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc |
NON-PROPRIETARY NAME: | Anagrelide Hydrochloride |
SUBSTANCE NAME: | ANAGRELIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-04-18 |
END MARKETING DATE: | 0000-00-00 |
Anagrelide Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Anagrelide Hydrochloride from Teva Pharmaceuticals USA, Inc |
LABELER NAME: | Teva Pharmaceuticals USA, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2005-04-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0172-5240_56ae5267-4bc1-4420-94a0-75df1567ca68 |
PRODUCT NDC: | 0172-5240 |
APPLICATION NUMBER: | ANDA076468 |
Other ANAGRELIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: